Sr. Director, US Channel Distribution

This role is considered Virtual.

Overview

Reporting to the Vice President, U.S. Market Access we seek an experienced and focused individual to manage and evolve Alnylam’s distribution channel from the 3PL downstream, for all US channels.  The primary objective of this role is to ensure the rapid and convenient distribution of Alnylam drug products to healthcare providers (HCPs) and patients.  The Senior Director, Channel Distribution is a key leader in the successful commercialization of Alynlam’s portfolio of medicines.  This individual sets strategic imperatives, leads our channel account management and operations teams, and ensures that the patient experience is maximized with Alnylam’s channel partners.  This role requires close collaboration with leaders in Product Supply, Patient Services, Commercial Leadership, Field Reimbursement, and other critical functions.

The successful candidate must be passionate about science and deeply motivated by the quest of delivering value to patients and their families with the long-term success of the company in mind.  

Key Responsibilities

• Oversee distribution operations, ensuring Alynlam products reach HCPs and patients in a timely and convenient manner
• Establish and maintain strong relationships and contractual agreements with channel partners
• Lead strategic and tactical planning for all channel activities
• Work closely with US Patient Services to ensure seamless integration of Specialty Pharmacy and Specialty Distribution partners into hub services
• Lead Channel Account Management team focused on maximizing the patient experience with channel partners
• Lead quarterly business reviews and other customer facing meetings to ensure that patients are receiving excellent service levels and fully benefit from Alnylam customer initiatives
• Manage, in collaboration with internal stakeholders, distribution policies and procedures including but not limited to orders, returns and inventory
• Collaborate with Alnylam Legal and Contracting to negotiate agreements and to ensure all relevant state licenses are current
• Work with Alnylam field personnel to provide key distribution channel analytics in the form of regular, actionable reports. Train field personnel on distribution strategy and programs
• Manage KPIs and reporting dashboards to track critical distribution metrics for launch and beyond
• Scale and refine the distribution strategy, over time, as appropriate with any future approved indication(s) and/or sites of care.
• Help set the overall U.S. Market Access strategy and ensure successful execution as a member of the U.S. Market Access Leadership team
• Ensures compliance with all corporate policies and industry codes in collaboration with Alnylam Legal, Regulatory and Compliance

Qualifications

• Pharmaceutical/biotech experience required
• 10+ yrs. of direct involvement in distribution operations and managing trade partners. Strong understanding of reimbursement dynamics are required.
• 5+ years of team leadership experience including hiring account management and operations team members
• Deep knowledge of US pharmaceutical channel dynamics, payer coverage and reimbursement environment, government policies pertaining to price reporting obligations, and contracting strategies
• Market Access Leadership Team experience preferred
• Exceptional interpersonal skills, professional communications, problem-solving, compassion and the ability to influence decision-making without direct authority
• Ability to work well and lead within with cross-functional groups and in a matrix organization
• Desire to innovate and work in a fast-paced, energetic environment
• Self-starter who is highly passionate about rare disease and Alnylam’s core values:
  • Commitment to People, Innovation, Discovery, Sense of Urgency, Open Culture, and Passion for Excellence.
• Undergraduate degree required, MBA preferred
• Ability to travel up to 30%

About Alnylam: Alnylam Pharmaceuticals (Nasdaq: ALNY) has led the translation of RNA interference (RNAi) into a whole new class of innovative medicines with the potential to transform the lives of people afflicted with rare and more prevalent diseases. Based on Nobel Prize-winning science, RNAi therapeutics represent a powerful, clinically validated approach to treating diseases at their genetic source by “interfering” with mRNA that cause or contribute to disease. Since our founding in 2002, Alnylam has led the RNAi Revolution and continues to turn scientific possibility into reality.

Our culture: Our people-first culture is guided by our core values: fiercely innovative, open culture, purposeful urgency, passion for excellence, and commitment to people, and these values influence how we work and the business decisions we make. Thanks to feedback from our employees over the years, we’ve been fortunate to be named a top employer around the world. Alnylam is extremely proud to have been recognized as one of Science Magazine’s Top Biopharma Employers, one of America's Most Responsible Companies for 2024 by Newsweek, a Fast Company Best Workplace for Innovators, and a Great Place to Work in Canada, France, Italy, Spain, Switzerland, and UK – among others.

At Alnylam, we commit to an inclusive recruitment process and equal employment opportunity. We are dedicated to building an environment where employees can feel that they belong, can bring their authentic selves to work, and achieve to their full potential. By empowering employees to embrace their unique differences at work, our business grows stronger with advanced and original thinking, allowing us to bring groundbreaking medicines to patients.